We sought to examine the concordance of two suicidal ideation items from the Patient Health Questionnaire-9 (PHQ-9) and the Edinburgh Postnatal Depression Scale (EPDS), to evaluate the prevalence of suicidal ideation among pregnant women, and to assess the co-occurrence of suicidal ideation with antepartum depressive symptoms. A cross-sectional study was conducted among 1,517 pregnant women attending prenatal care clinics in Lima, Peru. Item 9 of the PHQ-9 assesses suicidal ideation over the last 14 days while item 10 of the EPDS assesses suicidal ideation in the past 7 days. The two suicidal ideation items have a high concordance rate (84.2 %) but a moderate agreement (the Cohen's kappa = 0.42). Based on the PHQ-9 and the EPDS, 15.8 and 8.8 % of participants screened positive for suicidal ideation, respectively. Assessed by the PHQ-9, 51 % of participants with suicidal ideation had probable depression. In prenatal care clinics, screening for suicidal ideation is needed for women with and without depressive symptoms. Future studies are needed to identify additional predictors of antepartum suicidality, determine the appropriate duration of reporting period for suicidal ideation screening, and assess the percentage of individuals with positive responses to the two suicidal ideation items at high risk of planning and attempting suicide. / This research was supported by an award from the National Institutes of Health (NIH), the Eunice Kennedy Shriver Institute of Child Health and Human Development (R01-HD-059835). The NIH had no further role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The authors wish to thank the dedicated staff members of Asociacion Civil Proyectos en Salud (PROESA), Peru and Instituto Especializado Materno Perinatal, Peru for their expert technical assistance with this research. The authors would like to thank Kathy Brenner for her help with revising this manuscript. / Revisión por pares

ObjectifLe diagnostic prénatal (DPN) a pour but de détecter des pathologies foetales in utero. L’objectif de ce travail était de mettre au point et d’appliquer les techniques d’exploration chromosomique en prénatal. Nous avons, tout d’abord, validé et évalué une plateforme de séquençage basée sur la technologie des semi-conducteurs, Ion Proton®, pour le dépistage prénatal non-invasif (DPNI) des principales aneuploïdies en routine clinique, puis évalué l’intérêt de l’Analyse Chromosomique sur Puces à ADN (ACPA) dans le diagnostic prénatal des retards de croissance intra-utérin (RCIU) foetaux. Matériel et Méthodes Nous avons inclus prospectivement 2505 patientes enceintes analysées par huit laboratoires hospitalo-universitaires de génétique : 695 grossesses à haut risque pour la trisomie 21 (risque ≥1/250 ou avec anomalie échographique) dans une étude de validation de la technique du test ADN libre circulant (ADNlc), et 1810 grossesses à risque, sans anomalie échographique, en routine clinique. Les issues de grossesses étaient toutes disponibles dans l’étude de validation et pour 521 grossesses dans l’étude en routine clinique. L’ADNlc extrait d’échantillons plasmatiques était séquencé, puis les données étaient analysées à l’aide du logiciel WISECONDOR. Les résultats des tests ADNlc étaient comparés aux caryotypes foetaux ou 7 aux données à la naissance. Nous avons aussi évalué le taux d’échec et comparé trois méthodes d’évaluation de la fraction foetale (FF) (RASSF1A, DEFRAG et SANEFALCON). Nous avons rétrospectivement inclus tous les foetus référés pour un prélèvement invasif pour RCIU et étudié les résultats de technique d’hybridation in situ en fluorescence (FISH), caryotypes et ACPA. Résultats Les résultats des deux cohortes de l’étude sur l’ADNlc étaient cohérents et les âges gestationnels n’étaient pas significativement différents ; les données ont été combinées afin d’étoffer la cohorte à analyser. Respectivement, la sensibilité et la spécificité étaient de : 98.3% (95% IC, 93.5–99.7%) et 99.9% (95% IC, 99.4–100%) pour la trisomie 21; 96.7% (95% IC, 80.9–99.8%) et 100% (95% IC, 99.6–100%) pour la trisomie 18 ; et 94.1% (95% IC, 69.2–99.7%) et 100% (95% IC, 99.6–100%) pour la trisomie 13. Le taux de non rendus était de 1.2% initialement puis après réanalyse de 0.6%. L’estimation de la FF avec les méthodes RASSF1A et DEFRAG étaient comparables, toutes deux compatibles avec une utilisation en routine clinique. Parmi les 162 foetus RCIU (78 associés et 84 isolés) inclus dans l’étude ACPA, 15 avaient une FISH pathologique : 10 RCIU associés et cinq RCIU isolés. Parmi 143 foetus étudiés par ACPA, 10 (7%) présentaient un variant du nombre de copies (CNV), tous étaient des RCIUs associés (10/65 soit 15.4%; 95 IC: 8.4%‐26.2%), versus 0/78 dans le groupe RCIUs isolés (95% IC: 0%‐5.6%). Six foetus (4.2%) ont présenté des variants de signification inconnue (VSI) (trois RCIU associés et trois RCIU isolés). Conclusion : Notre étude évaluant le test ADNlc utilisant la technologie des semi-conducteurs est la première étude clinique à rapporter les issues de grossesses dans une population aussi large. La plateforme est performante pour le DPNI des principales aneuploïdies. Notre protocole robuste est facilement applicable en routine clinique. Notre étude souligne une augmentation de rendement diagnostique de l’ACPA de 6.1% (4/65) par rapport au caryotype pour le DPN des foetus présentant un RCIU associé. Aucun CNV pathogène n’a été mis en évidence dans le groupe RCIU isolé. L’ADNlc pourrait-il supplanter l’ACPA dans cette population de RCIU isolé ? Le développement du test ADNlc a permis de limiter le nombre de prélèvements invasifs et donc leurs complications [...]. / ObjectivePrenatal diagnosis allows to detect fetal pathologies in-utero. The goal of this work was both technical development and application of the chromosomal exploration technics in prenatal diagnosis. First, we aimed to validate and evaluate the performance metrics of the highthroughput semiconductor sequencing platform, Ion Proton®, in non-invasive prenatal genetic screening (NIPS) for common fetal aneuploidies in a clinical setting and, then to evaluate the diagnostic utility of prenatal diagnosis using the chromosomal microarray analysis (CMA) for fetuses presenting with isolated or associated intrauterine growth restriction (IUGR). Methods : First, regarding NIPS, a prospective cohort study including 2505 pregnant women from eight academic genetics laboratories (695 high risk pregnancies for trisomy 21 (risk ≥1/250 or with ultrasound anomalies) in a validation study, and 1810 such pregnancies, without ultrasound anomalies, in a real-life NIPS clinical setting) was conducted. An outcome was available for all cases in the validation cohort and for 521 in the clinical cohort. Cell-free DNA from plasma samples was sequenced using the Ion Proton sequencer, and sequencing data were analyzed using the open-access software, WISECONDOR. Performance metrics for detection 10 of trisomies 21, 18 and 13 were calculated based on either fetal karyotype result or clinical data collected at birth. We also evaluated the failure rate and compared three methods of fetal fraction quantification (RASSF1A assay, and DEFRAG and SANEFALCON software). Then, regarding the CMA study, we retrospectively included all fetuses with IUGR referred for prenatal testing and studied by rapid fluorescence in situ hybridization (FISH), karyotype, and CMA. Results :In the NIPS study, results from both cohorts were consistent and their gestational age was not significantly different, so their data were combined to increase the sample size for analysis. Sensitivities and specificities, respectively, were as follows: for trisomy 21, 98.3% (95% CI, 93.5–99.7%) and 99.9% (95% CI, 99.4–100%); for trisomy 18, 96.7% (95% CI, 80.9–99.8%) and 100% (95% CI, 99.6–100%); and for trisomy 13, 94.1% (95% CI, 69.2–99.7%) and 100% (95% CI, 99.6–100%). Our failure rate was 1.2% initially and as low as 0.6% after retesting some of the failed samples. Fetal fraction estimation by the RASSF1A assay was consistent with DEFRAG results, and both were adequate for routine diagnosis. Among the 162 IUGR fetuses (78 associated and 84 isolated IUGR) included in the CMA study, 15 had an abnormal FISH result: 10 associated and five isolated fetal IUGRs. Among the 143 fetuses studied by CMA, 10 (7%) presented pathogenic copy number variations (CNVs). All 10 were in the associated fetal IUGR group (10/65 or 15.4%; 95% confidence interval [CI]: 8.4%‐26.2%) versus 0/78 in the isolated fetal IUGR group (95% CI: 0%‐5.6%). Six fetuses (4.2%) carried variants of unknown significance (VOUS) (three associated and three isolated fetal IUGRs). Conclusion: We described one of the largest studies evaluating Ion Proton-based NIPS and the first clinical study reporting pregnancy outcome in a large series of patients. This platform is highly efficient in detecting the three most common trisomies. Our protocol is robust and can be implemented easily in any medical genetics’ laboratory. Our second study highlighted the added value of CMA in the case of associated fetal IUGR with an incremental yield of 6.1% (4/65) over karyotyping. No pathogenic CNVs were reported in the isolated fetal IUGR group. Could NIPS supplant CMA in isolated fetal IUGR? The development of the NIPS test has reduced prenatal invasive testing and therefore its complications [...].

MPH / Department of Public Health / The high maternal mortality ratio is caused by various factors, including avoidable complications which can be reduced by attendance to antenatal care visits. The utilisation of antenatal care has been low in rural areas, especially in Africa. The purpose of this study was to explore the utilisation of antenatal care in Mutasa District of Zimbabwe. This study used a qualitative study approach, adopting the descriptive, explorative design that presented an active image of the research participants’ reality and capture live experiences. Participants of the study were pregnant women and women with children under the age of one. The participant were sampled using purposive and snow-ball sampling techniques. In-depth interviews were conducted. The participants were interviewed in their native language, Shona. The main question was: Can you explain in your own words how you use antenatal care services from the primary health care facility? The researcher clarified questions which the participant failed to understand. The researcher wrote down all responses and used a tape recorder to capture the responses. The researcher analysed data using thematic content analysis where themes and sub-themes were discussed. The main theme was low uptake of antenatal care in rural primary health care facilities. From the main theme there were factors influencing and perceptions of women on uptake of antenatal care services in primary health care facilities. Trustworthiness was ensured through credibility, dependability, transferability and conformability. Permission from the relevant authorities, such as the University of Venda Higher Degrees Committee, the Provincial Medical Director and the District Administrator was sought before conducting this study. Informed consent was also sought before interviewing the participants. The study concluded that socio-demography of participants affected antenatal care attendance. These are age, level of education, low income, high parity and distance to facility. Other hindering factors to utilization of antenatal care were lack of knowledge, religion and acceptability of antenatal care by the women in rural primary health care facilities. Findings will be disseminated through a research report and published in relevant accredited journals with the help of the supervisors. The study recommended that the Ministry of Health and Child Care of Zimbabwe review Antenatal Care policies to ensure friendliness and to increase awareness through health education and continuous dissemination of antenatal care information. / NRF

Since the discovery of cell-free fetal DNA in peripheral blood of pregnant women, cell-free nucleic acids in maternal plasma are explored in relation to non-invasive prenatal diagnosis of various fetal conditions and pregnancy complications. Non-invasive prenatal diagnosis of monogenic diseases represented by TSC1-linked tuberous sclerosis could be achieved by detection of paternally-inherited mutant allele in the pool of maternal alleles in plasma. Reliability of detection of mutant allele could be improved by simultaneous mutation haplotype analysis or detection of universal fetal marker. None of the 3 methods (allele- specific real-time PCR, SNaPshot minisequencing and quantitative fluorescent PCR) evaluated using artificial mixtures and maternal plasma samples reliably and accurately detected low-frequency allele distinguished by point mutation, SNP or microsatellite in TSC1 gene or in its close proximity. We developed a strategy for prediction of proportion of informative couples for panel of SNPs of interest that can be applied to any monogenic disease. Exploiting differential methylation of promoters of genes RASSF1A, HLCS and OLIG2 in maternal and fetal genome, we failed to establish functional fetal marker. MicroRNAs of placental origin released into plasma could serve as biomarkers of...

Bei ca. 10 bis 20 % aller Totgeburten wird autoptisch eine Lungenhypoplasie diagnostiziert. Nierenfehlbildungen, vorzeitiger Blasensprung, Hydrops fetalis und Skelettfehlbildungen sind häufige Ursachen eines Minderwuchses der Lunge, der immer mit einer schlechten Prognose einhergeht. Bis heute gibt es jedoch kein zuverlässiges Verfahren zur pränatalen Diagnose einer Lungenhypoplasie, die das geburtshilfliche Management erheblich erleichtern könnte. Bei Totgeburten wird eine Lungenhypoplasie pathologisch-anatomisch durch einen verminderten Lungen / Körpergewichts-Index (L/KG- Index) und einen verringerten Radial Alveolar Count (RAC) belegt. Ziel dieser Studie war es, ein sonographisches Verfahren zu validieren, mit dem man eine fetale Lungenhypoplasie schon während der Schwangerschaft diagnostizieren könnte. Die Untersuchung basierte auf gestationsaltersabhängigen Referenzwerten für verschiedene Biometrieparameter, die das fetale Lungenwachstum gut erfassen. Die aufgestellten Normkurven wurden hinsichtlich ihres prädiktiven Werts zur Vorhersage einer Lungenhypoplasie geprüft. Dazu wurden Messungen bei 39 Feten mit einem hohem Risiko zur Entwicklung einer Lungenhypoplasie zwischen der 17. und 30. SSW vorgenommen. Zur Auswertung gelangten nur die 29 Fälle, bei denen der Verdacht einer Lungenhypoplasie pathologisch-anatomisch belegt oder widerlegt wurde. Die Patienten wurden vier verschiedenen Krankheitsbildern zugeordnet: Vorzeitiger Blasensprung, Hydrothorax, Nierenfehlbildungen und Skelettfehlbildungen. Es wurden jeweils der anterior-posteriore und der seitliche Durchmessers in Höhe des Zwerchfells, des Vierkammerblicks und der Clavicula sowie die Lungenlänge gemessen. Untersuchungen in der Vierkammerblickebene hatten mit einer Sensitivität von 61 % und einer Spezifität von 75 % die höchsten prädiktiven Werte zur Vorhersage einer fetalen Lungenhypoplasie. Die Untersuchung in der VKB-Ebene hat den Vorteil, daß die Einstellung dieser Ebene bei Routineultraschalluntersuchungen während der Schwangerschaft durchgeführt wird und so in der Praxis am ehesten zur Anwendung kommt. Im Vergleich zur Literatur ist unser Verfahren auch in der Vierkammerblickebene zur pränatalen Diagnose einer Lungenhypoplasie relativ unzuverlässig. Messungen in der Clavicula- und der Zwerchfellebene und Messungen der Lungenlänge waren in dieser Untersuchung zur pränatalen Diagnose einer Lungenhypoplasie ungeeignet. Mit Sensitivitäten zwischen 13 % und 47 % stellten sie keine Hilfestellung zur Vorhersage eines Minderwuchses der fetalen Lunge dar. Die Aufschlüsselung der Feten in einzelne Krankheitsbilder erbrachte weitere Informationen. Dabei wurden nur die Messungen in der VKB-Ebene ausgewertet. Bei den Feten mit vorzeitigem Blasensprung, Hydrothorax und Skelettfehlbildungen lagen die Sensitivitäten zwischen 60 % und 100 % und waren mit den Ergebnissen aus der Literatur vergleichbar. Bei den Feten mit Nierenfehlbil-dungen waren die Ergebnisse mit Sensitivitäten von 27 % enttäuschend. Bei der Auswertung wurde deutlich, daß es von großer Bedeutung ist, sowohl den anterior-posterioren als auch den seitlichen Durchmesser zu messen, da nur so zuverlässig die Ausdehnung der Lunge zu erfassen ist. Insgesamt kann das biometrische Verfahren als einfache, gut reproduzierbare, nicht invasive und schnell durchzuführende Möglichkeit zur Untersuchung der fetalen Lunge bezeichnet werden. Es kann wichtige Hinweise geben, eine Lungenhypoplasie schon pränatal zu diagnostizieren. Eine sichere Einschätzung ist jedoch nicht möglich. Neben der Lungenbiometrie könnten evtl. auch Messungen der fetalen Atembewegungen, Messungen der Fruchtwassermenge und dopplersonographische Darstellung der Lungengefäße zur Diagnose beitragen. Letztendlich bleibt eine Lungenhypoplasie eine pathologisch-anatomische Diagnose, die nur durch Autopsie gesichert werden kann. Inwiefern hier neue Aspekte in die Diagnosestellung einbezogen werden können, bleibt zukünftigen Untersuchungen vorbehalten. / Evaluation of sonographic lung biometry as a method to diagnose lung hypoplasia prenatallyIn 10 to 20 % of all stillbirths lung hypoplasia can be diagnosed by autopsy. Causes for the underdevelopment of the lung, which indicates poor prognosis, are urinary tractanomalies, preterm rupture of membranes, hydrops fetalis and skeletal dysplasia. Up to now there is no reliable method to diagnose lung hypoplasia prenatally. In stillbirths lung hypoplasia is proven by autopsy by a decreased lung/body weight index and a low radial alveolar count (RAC). Aim of this study was to evaluate a sonographic method to diagnose lung hypoplasia during pregnancy. The examination was based on normograms for different biometrical parameters, which describe the fetal lung growth between the 15th and the 30th week gestation. The predictive value of the reference curves was determined. 39 fetuses at high risk for developing lung hypoplasia were examined sonographically between the 17th and 30th week gestation. Only the measurements of 29 fetuses, whose diagnosis was proven or disproven by autopsy, were evaluated. The patients were splitted into four groups: preterm rupture of membranes, hydrothorax, urinary tract anomalies and skeletal dysplasia. In each fetus seven different parameters were measured: the anterior-posterior and the transverse diameter at the level of the diaphragm, the four chamber view and the clavicula and additionally the lung length. The best results were found at the level of the four chamber view (sensitivity 61 % and specifity 75 %). An advantage of measurements at the level of the four chamber view is that this examination is performed in normal routine Ultrasound tests during pregnancy. So measurements in this plane could become most important in clinical life. In comparison to other published studies even at the level of the four chamber view our method was not reliable to predict fetal lung hypoplasia. Measurements at the level of the clavicula and of the diaphragm and measurements of the lung length were not useful to diagnose lung hypoplasia before birth. Sensitivities between 13 and 47 % were found. Splitting the fetuses into different etiological groups gave additional information. Only the measurements at the level of the four chamber view were evaluated. In the groups preterm rupture of membranes, hydrothorax and skeletal dysplasia sensitivities between 60 and 100 % were found. These results can be compared with published results. In the group urinary tract anomalies the result was disappointing (sensitivity 27 %). During the evaluation it could be seen easily that it was very important to measure the anterior-posterior as well as the transverse diameter. Only this technique gives the possibility to measure the whole extension of the lung. Summarizing: The biometrical method is a simple, easily reproducable, not invasive and quick possibility to examine the fetal lung. It can help to predict fetal lung hypoplasia. However a reliable diagnosis could not be made. In addition to lung biometry measurements of the the fetal breathing excursions, measurements of the amount of amniotic fluid and examination of the pulmonal circulation may be useful for a prenatal diagnosis. Up to now lung hypoplasia only can be proved by autopsy. It has to be examined in future studies, if any new aspects can help to find a prenatal diagnosis.

In einer retrospektiven Studie über den Zeitraum von 1990-2000 wurden in der Klinik für Kinderchirurgie des Universitätsklinikums Charité, Berlin die Kinder untersucht, bei denen eine lymphatische Malformation aufgetreten war. Es ergaben sich insgesamt 18 Patienten. Parallel wurden aus der Klinik für Gynäkologie und Geburtshilfe, Abteilung für Pränatale Diagnostik und Therapie des Universitätsklinikums Charité, Berlin retrospektiv für den oben genannten Zeitraum 31 Patientinnen untersucht, bei deren Feten ein zystisches Nackenhygrom im Verlauf der Schwangerschaft diagnostiziert worden war. Ziel der Arbeit war es, die geeigneteste Therapieform in der Behandlung von lymphatischen Malformationen im Kindesalter in besonderen Hinsicht auf die Prognose, Rezidivfreiheit und Spätergebnisse zu untersuchen. Parallel galt es zu evaluieren, ob in Anbetracht der pränatalen Diagnostizierbarkeit lympahtischer Malformationen und dem postnatal sich daraus ergebenden Krankheitsverlauf eine Schwangerschaftsunterbrechung in Erwägung gezogen werden sollte. / A ten year retrospective study of 18 children with lymphatic malformation and 31 pregnant women with fetal cystic hygromas was carried out at the Department of Pediatric Surgery and the Department of Obstetrics and Gynaecology at the University Hospital Charité, Berlin. The objective of this study was to analyze the most effective therapy for lymphatic malformation in children with regard to the children prognosis, the recurrences after treatment and the long-time-follow-up. Another object to analyze was the point of prenatal diagnosis of fetal cystic hygromas and the adverse fetal outcome.

Einleitung: Fehlbildungen der Nieren und ableitenden Harnwege gehören zu den häufigsten angeborenen Anomalien. Ihr Anteil an den pränatal diagnostizierten Fehlbildungen wird mit bis zu 50% angegeben. Die Behandlung urogenitaler Fehlbildungen hat sich nicht zuletzt unter dem Einfluss der Pränatalen Diagnostik erheblich gewandelt. Nach einer Phase der Übertherapie nach Einführung der pränatalen Diagnostik ergab sich nach modernen diagnostischen Kriterien und im Ergebnis von Langzeitstudien des natürlichen Ganges der Fehlbildungen eine wesentlich differenziertere Indikationsstellung für das aktive therapeutische Vorgehen Fragestellung: In der retro- und prospektiv angelegten Studie sollte untersucht werden, inwieweit die pränatale Diagnostik das postnatale Vorgehen beeinflusst. So sollte untersucht werden, aus welchen pränatalen Befunden welche pränatalen Verdachtsdiagnosen gestellt wurden und wie sich diese zu den definitiven postnatalen Diagnosen verhalten. Des weiteren sollte der Aussagewert einzelner pränataler Befunde herausgearbeitet werden. Besondere Beachtung sollte dabei die Frage finden, inwieweit aus den pränatalen Befunden eine Aussage über die postnatale Therapiebedürftigkeit und schließlich auch für die Prognose der Nierenfunktion möglich ist. Patienten und Methoden: Ausgangspunkt waren 21.616 in der Abteilung für pränatale Diagnostik und Therapie in der Zeit von 1984 bis 1996 untersuchte Schwangerschaften. Unter diesen fanden sich 1.574 Feten mit angeborenen Anomalien mit fraglich kinderchirurgischer Relevanz. 1077 Fälle konnten ausgewertet werden. Mit 990 Fällen dominierten die Fehlbildungen des Urogenitalsystems, von denen 693 in die komplette Analyse mit einbezogen werden konnten. Ergebnisse: Bei 7,28% aller untersuchten Feten fanden sich Organfehlbildungen außerhalb des Zentralnervensystems. Unter diesen dominierten Harntraktfehlbildungen mit 63%. Als häufigste Diagnose wurde pränatal eine "Hydronephrose" angegeben. Dieser Begriff umschreibt jedoch in dem hier verwandten Sinne eine Harntransportstörung jeglicher Ursache. Echte Diagnosen obstruktiver Uropathien wurden lediglich zu 30% in den einzelnen Gruppen gestellt. Die pränatalen Verdachtsdiagnosen bestätigen sich zu zwischen 80 und 90% wenn: - eine isolierte Hydronephrose mit einem Nierenbeckendurchmesser von über 10 mm als Ureterabgangsstenose befundet wurde - die typische Konfiguration einer Multizystischen Nierendysplasie gefunden wurde - aus der Kombination von Oligohydramnion, Megazystis und bilateraler Harntransportstörung des männlichen Feten auf Urethralklappen geschlossen wurde. Lediglich bei der unilateralen multizystischen Nierendysplasie und der subpelvinen Obstruktion wird im pränatalen Befund bezüglich der definitiven Diagnose eine akzeptable Sensitivität und Spezifität erreicht. Alle anderen Diagnosen werden zu 70% postnatal gestellt. Der Einfluss der pränatalen Diagnostik auf das postnatale Management bezieht sich in erster Linie auf die Aufdeckung vorerst symptomloser Fehlbildungen. Eine pränatale Aussage über die zu erwartende Nierenfunktion ist bei einseitigen Fehlbildungen derzeit nicht möglich. Zusammenfassung: Obstruktive Uropathien sind häufige, zumeist benigne Fehlbildungen. Sie sind der pränatalen Diagnostik gut zugänglich. Konkrete Diagnosen mit Aussagen zur postnatalen therapeutischen Relevanz können jedoch nur gestellt werden, wenn sonografisch pathognomonische Konstellationen dies ermöglichen. In allen anderen Fällen muss die pränatal beschriebene Auffälligkeit Anlass zu postnataler sorgfältiger Diagnostik sein, um im präsymptomatischen Intervall die Entscheidung zu konservativer oder operativer Therapie stellen zu können. / Introduction: Among congenital dysplasias the anomalies of kidney and urogenital tract are among the most frequent encountered. Their rate in prenatally made diagnoses is about 50 %. Modern prenatal diagnostic facilities have changed the therapeutic access to these anomalies in the last decade. After a phase of overtreatment in the beginning, nowadays new insights in the natural course of these dysplasias and the results of long-term follow-up studies resulted in a more differentiated apporach. Questions and methods: In this retro- and prospective study we looked for the the influence of prenatal diagnostics on the postnatal course and management. The question was to examine the relationship between the prenatal ultrasound results, the suggested prenatal diagnosis and then the defintive postnatal disease. Of interest was the prognostic impact of typical prenatal sonographic imaging on the postnatal course of the baby. Because of its frequency we focused on anomalies of the kidney and urogenital tract. Patients: Between 1984 and 1996 21.616 pregnancies were examined by ultrasound in our Department of Prenatal Medicine. Among these, 1.574 anomalies of surgical relevance were described. 1.077 cases were available for follow-up including 990 cases of urogenital anomalies. Among these, the records of 693 cases were complete and these patients form the collective of this study. Results: When the CNS was excluded we found organic anomalies in 7,28 % of these cases. Among them 63% were attributed to the urogenital system. The most common prenatal diagnosis was "hydronephrosis". But this term was used only in a descriptive manner because proof of a real obstructive uropathy postnatally was made only in 30% of these cases. Concerning all anomalies of the urogenital tract, the prenatal diagnosis proved correct in the overwhelming majority of cases ( 90%) if these sonographic signs have been described: - diameter fo the renal pelvis of more than 10 mm in isolated hydronephrosis predicted ureteropelvic junction obstruction - typical formation of a multicystic dysplastic kidney - combination of oligohydramnion, megacystis and bilateral kidney anomalies in a male fetus predicted posterior urethral valve disease Sensitivity and specifity in regard to the definitive diagnosis were acceptable in multicystic dysplasia of the kidney and ureteropelvic junction obstruction. In all other cases, the correct diagnosis was made postnatally in 70 %. Therefore, the main value of prenatal sonography was to reveal otherwise symptomless dysplasias. Until now, a prenatal prediction of kidney function in the unilateral case is not possible. Conclusion: Obstructive uropathies are common an in most cases benign anomalies. They are easily detected by prenatal ultrasound. Therapeutical consequences, however, only arise in selected cases if typical sonographic signs can be seen. In the majority of cases, therefore, the main purpose of prenatal diagnostic ultrasound points out the necessity for postnatal diagnostic workup in order to detect and treat severe diseases before symptoms occur.

Le caryotype moléculaire permet d’identifier un CNV chez 10-14% des individus atteints de déficience intellectuelle et/ou de malformations congénitales. C’est pourquoi il s’agit maintenant de l’analyse de première intention chez ces patients. Toutefois, le rendement diagnostique n’est pas aussi bien défini en contexte prénatal et l’identification de CNVs de signification clinique incertaine y est particulièrement problématique à cause du risque d’interruption de grossesse. Nous avons donc testé 49 fœtus avec malformations majeures et un caryotype conventionnel normal avec une micropuce CGH pangénomique, et obtenu un diagnostic dans 8,2% des cas. Par ailleurs, des micropuces à très haute résolution combinant le caryotype moléculaire et le génotypage de SNPs ont récemment été introduites sur le marché. En plus d’identifier les CNVs, ces plateformes détectent les LOHs, qui peuvent indiquer la présence d’une mutation homozygote ou de disomie uniparentale. Ces anomalies pouvant être associées à la déficience intellectuelle ou à des malformations, leur détection est particulièrement intéressante pour les patients dont le phénotype reste inexpliqué. Cependant, le rendement diagnostique de ces plateformes n’est pas confirmé, et l’utilité clinique réelle des LOHs n’est toujours pas établie. Nous avons donc testé 21 enfants atteints de déficience intellectuelle pour qui les méthodes standards d’analyse génétique n’avaient pas résulté en un diagnostic, et avons pu faire passer le rendement diagnostique de 14,3% à 28,6% grâce à l’information fournie par les LOHs. Cette étude démontre l’utilité clinique d’une micropuce CGH pangénomique chez des fœtus avec malformations, de même que celle d’une micropuce SNP chez des enfants avec déficience intellectuelle. / Molecular karyotyping identifies a CNV in 10-14% of individuals affected with intellectual disability and/or congenital abnormalities. Therefore, it is now the first-tier analysis for these patients. However, the diagnostic yield is not as clear in the prenatal context, and the risk of pregnancy termination makes the detection of variants of uncertain clinical significance particularly problematic. We tested 49 fetuses with major malformations and a normal karyotype, using a pangenomic CGH array, and obtained a diagnosis in 8.2% of cases. Furthermore, high-resolution microarrays combining molecular karyotyping and SNP genotyping were recently introduced on the market. In addition to identifying CNVs, these platforms detect LOHs, which can indicate the presence of a homozygous mutation or of uniparental disomy. Since these abnormalities can be associated with intellectual disability or congenital abnormalities, their detection is of particular interest for patients whose phenotype remains unexplained. However, the diagnostic yield obtained with these platforms is not confirmed, and the real clinical value of LOH detection is not yet established. We tested 21 children affected with intellectual disability for whom standard genetic analyses failed to provide a diagnosis, and were able to increase the diagnostic yield from 14.3% to 28.6% as a result of the information provided by LOHs. This study shows the clinical usefulness of pangenomic CGH arrays in fetuses with malformation(s), as well as that of SNP arrays in children with intellectual disability.

A partir de données en population, nous avons: 1) évalué le risque de cardiopathies congénitales (CC) chez les fœtus conçus par assistance médicale à la procréation (AMP); et 2) déterminé les effets de l’AMP sur la prise en charge prénatale et le devenir périnatal des fœtus porteurs de CC. Nous avons observé que l'AMP était associée à une augmentation de 40% du risque de CC sans anomalies chromosomiques associées (OR ajusté = 1,4 IC95% 1,1-1,7). Nous avons également retrouvé qu'il existait des associations variables selon la catégorie de CC et la méthode d'AMP considérées. Nous avons observé que l'AMP était associée à une multiplication par 2,4 du risque de tétralogie de Fallot (OR ajusté = 2,4 IC95% 1,5-3,7), alors que nous n’avons pas retrouvé d’association statistiquement significative pour les trois autres CC spécifiques étudiées. Dans notre population, l'exposition à l'AMP ne semblait pas modifier le recours au diagnostic prénatal et à l'interruption médicale de grossesse chez les fœtus porteurs de CC comparés aux fœtus porteurs de CC conçus spontanément. Nous avons par ailleurs observé que le risque de prématurité des fœtus porteurs de CC conçus par AMP était environ 5 fois plus élevé que celui des fœtus porteurs de CC conçus spontanément (OR ajusté = 5,0 IC95% 2,9-8,6). En nous basant sur une méthodologie d'analyses de cheminement, nous avons retrouvé que les grossesses multiples contribuaient pour environ 20% au risque plus élevé de tétralogie de Fallot associé à l'AMP que nous avons observé. Enfin, les grossesses multiples contribuaient pour environ 2/3 du risque de prématurité associé à l'AMP chez les fœtus porteurs de CC. / Using population-Based data, we: 1) assessed the risk of congenital heart defects (CHD) in assisted reproductive techniques (ART) conceived fetuses; and 2) evaluated the effects of ART on prenatal management and perinatal outcomes of fetuses with CHD. We observed that ART were associated with a 40% increased risk of CHD without associated chromosomal anomalies (adjusted OR = 1.4 95%CI 1.1-1.7). We also found varying associations between the different methods of ART and categories of CHD. We observed that ART were associated with 2.4-Higher odds of tetralogy of Fallot (adjusted OR = 2.4 95%CI 1.5-3.7), whereas no statistically significant association was found for the three other specific CHD included. In our population, ART exposure did not seem to modify prenatal diagnosis and termination of pregnancy for fetal anomaly in fetuses with CHD compared to fetuses with CHD conceived spontaneously. The risk for premature birth in fetuses with CHD conceived following ART was 5-Fold higher as compared to fetuses with CHD conceived spontaneously (adjusted OR = 5.0 95%CI 2.9-8.6). Using a path-Analysis method, we found that multiple pregnancies contributed for about 20% to the higher risk of tetralogy of Fallot associated with ART that we had found. Finally, multiple pregnancies contributed for the 2/3 of the risk of premature birth associated with ART in fetuses with CHD.

Cette thèse analyse les pratiques du diagnostic prénatal (DPN) en France et au Brésil, entre mondialisation des savoirs et des techniques et régulations locales, à la recherche des modalités d’anticipation du handicap. Le DPN s’est développé dans les pays d’Europe et d’Amérique du Nord en lien direct avec les législations sur l’avortement. Il a pris ancrage dans le suivi des grossesses comme l’un des modes de prévention des handicaps à la naissance. Son expansion aux pays où l’accès à l’avortement est restreint oblige à des adaptations fonction des régulations locales. Les dispositifs réglementaires encadrent le travail professionnel (travail en réseau, pluridisciplinarité) et l’enregistrement des pratiques (omniprésent en France, absent au Brésil). Ils modulent, en France, l’expérience des femmes ayant vécu une interruption de grossesse pour pathologie fœtale, comme en témoigne l’analyse de questionnaires semi directifs soumis à deux groupes de femmes à deux époques différentes. En 1999 les femmes réclament plus d’autonomie dans la prise de décision d’interruption. En 2005, elles sollicitent plus volontiers une décision partagée avec les praticiens, mais considèrent que la décision leur revient plus spécifiquement lors des termes tardifs, dans les situations à risque de retard mental, de grande incertitude pronostique, ainsi que dans le cadre de situations spécifiquement recherchées lors du parcours anténatal (telle la trisomie 21). Ces dispositifs réglementaires conditionnent aussi l’usage des techniques et les informations délivrées aux couples. Au Brésil, dans un contexte d’accès restreint à l’avortement et de fortes inégalités sociales, l’échographie en situation de normalité foetale glorifie la « naissance sociale anticipée» de l’enfant et de sa famille. En cas d’anomalie fœtale, une rupture radicale se produit. A l’hôpital public, qui concerne la majorité des femmes, la poursuite obligée de la grossesse règle l’attitude des praticiens : l’étude ethnographique menée à Rio de Janeiro montre que les obstétriciens optent alors pour l’éducation des femmes (dans l’espoir d’un accès progressif à l’autonomie, chemin espéré vers une société plus juste). Les pédiatres provoquent pour leur part un glissement sémantique proposant une utilisation positive de l’incertitude médicale qui modifie le cadre de la réflexion préservant une approche dynamique de l’accueil de l’enfant. Dans le secteur privé au Brésil, les interruptions de grossesse possibles hors des cadres légaux, sont maintenues sous le sceau du secret et ne laissent que peu entrevoir la dynamique décisionnelle préalable. L’anticipation du handicap lors des consultations prénatales met partout en avant la crainte du retard mental et de la souffrance pour l’enfant, le couple ou la fratrie, mais le discours varie selon les contextes : l’analyse comparative des observations souligne qu’en France, les praticiens utilisent la médecine basée sur les preuves pour informer le couple et réduire risques et incertitude en vue d’un choix nécessaire et dans le respect de l’autonomie décisionnelle des couples. Au Brésil, à l’hôpital public, la hiérarchie des priorités diffère: devenir mère, avoir un enfant vivant passent au premier plan. Le risque est présenté comme faisant partie de la vie et l’incertitude dynamique préserve l’avenir de l’enfant malade au sein de sa famille. Ces approches différenciées du risque et du handicap amènent à évoquer les évolutions récentes du champs du handicap qui ont peu pénétré l’univers du DPN. Portées notamment par les « disability studies », études menées par les personnes elles mêmes concernées par le handicap, elles considèrent le handicap comme un processus dynamique résultant d’une interaction entre l’état de santé et une situation sociale donnés. La thèse suggère en conclusion un rapprochement des savoirs, des expériences et des pratiques entre l’univers du prénatal et celui du handicap par le biais d’un dialogue inter et transdisciplinaire. / In search of modes of anticipating disability, this thesis examines and compares prenatal diagnosis (PND) practices in France and Brazil. In Europe and North America, PND has developed directly in line with legislation on abortion and is rooted in the monitoring of pregnancy, as one of the ways of preventing disability at birth. Its expansion into countries where access to abortion is restricted, is led by the globalization of knowledge and techniques, and has to be adapted to suit local regulations. Regulatory frameworks govern professional work (networking, multidisciplinarity) and the recording of PND practices (omnipresent in France, non-Existent in Brazil). As can be seen from our analysis of semi-Directive questionnaires given to two groups of women at two different periods of time, in France such mechanisms modulate the experiences of women who have undergone an abortion due to a foetal pathology. In 1999 women wanted greater autonomy when deciding whether or not to terminate a pregnancy. In 2005 they were more readily in favour of sharing decision-Making with doctors, but felt that the decision was theirs to make when it was a question of late-Term pregnancies, of situations with a risk of mental retardation, of major prognostic uncertainty, and of situations subject to specific tests during the prenatal period (such as Down’s Syndrome). These regulatory mechanisms also affect how technical tools are used and the information given to couples. In Brazil, in a context of restricted access to abortion and of very significant social inequality, an ultrasound in a situation of foetal normality glorifies the “anticipated social birth” of the child and its family. When a foetal anomaly is diagnosed, a radical rupture occurs. In public hospitals – used by the majority of women – obligatory continuation of pregnancy regulates doctors’ attitudes: the ethnographic study carried out in Rio de Janeiro shows that obstetricians have opted for the education of women (in the hope of gradual access to autonomy, hopefully the road towards a fairer society). Paediatricians produce a semantic shift, encouraging a positive use of medical uncertainty, which modifies the decision-Making framework and maintains a dynamic approach to welcoming the child-To-Be. In the private sector in Brazil, terminations of pregnancy which are possible outside of any legal framework are kept behind a wall of secrecy, revealing next to nothing about the prior decision-Making process. During prenatal consultations, the anticipation of a disability systematically brings out fears of mental retardation and of the suffering which will be caused to the child, the couple or siblings, but the discourse varies, depending on the context: a comparative analysis of our observations shows that, in France, doctors use evidence-Based medicine to inform couples and to reduce risks and uncertainties with a view to making a necessary choice, whilst at the same time respecting the couple’s decision-Making autonomy. In public hospitals in Brazil, there is a different hierarchy of priorities: the primary focus is that of becoming a mother and having a life-Born child. Risk is presented as being part of life and the dynamic aspects of medical uncertainty safeguard the future of the “sick” child within its family. These differentiated approaches to risk and disability lead us to consider recent evolutions in the field of disability which has so far had little impact on PND. Led in particular by “disability studies” – studies carried out by people who are themselves affected by disability – these evolutions consider disability to be a dynamic process resulting from an interaction between a given state of health and a given social situation. In its conclusion, the thesis suggests that the knowledge, experiences and practices of the prenatal world and that of disability be brought together through inter and transdisciplinary dialogue. / Essa tese analisa as práticas de diagnóstico pré-natal (DPN) na França e no Brasil, entre a mundialização de saberes, técnicas e regulações locais, focando as modalidades de antecipação da deficiência. O DPN desenvolveu-se nos países da Europa e América do Norte de forma diretamente relacionada com as leis sobre o aborto. Enraizou-se no monitoramento da gravidez como um dos modos de prevenção das deficiências. Sua expansão em países onde o acesso ao aborto é restrito leva a adaptações de acordo com as regulamentações locais. Disposições regulamentares enquadram o trabalho profissional (em rede, pluridisciplinar) e o registro das práticas (onipresente na França e ausente no Brasil). Elas modulam, na França, a experiência de mulheres que se submeteram ao aborto devido a uma patologia fetal, conforme evidenciado pela análise de questionários semi-estruturados aplicados em dois grupos de mulheres em duas épocas diferentes. Em 1999, as mulheres exigiam mais autonomia na tomada de decisões de interrupção. Em 2005, elas procuravam mais frequentemente uma decisão compartilhada com os médicos, porém consideravam que a decisão cabia a elas, especificamente em gestações mais adiantadas, em situações com risco de retardo mental, com elevada incerteza prognóstica, e no contexto de situações específicas rasteadas ao longo do percurso pré-natal (tal como a síndrome de Down).Estes mecanismos reguladores também condicionam o modo de utilização das técnicas e as informações fornecidas para os casais. No Brasil, em um contexto de acesso restrito ao aborto e de fortes desigualdades sociais, a ultrassonografia em situações de normalidade fetal glorifica o "nascimento social antecipado" da criança e a « ampliação » da família. Em caso de anomalia fetal, uma ruptura radical se produz.No hospital público, para onde vai a maioria das mulheres, a impossibilidade de interromper a gestação define a atitude dos profissionais: o estudo etnográfico realizado no Rio de Janeiro mostra que os obstetras optam então pela educação das mulheres (na esperança de um ganho progressivo de autonomia, em direção a uma sociedade mais justa). Os pediatras realizam, por sua vez, uma mudança semântica, proporcionando um uso positivo da incerteza médica que muda o contexto do debate, preservando uma abordagem dinâmica sobre a chegada da criança. No setor privado no Brasil, a interrupção da gravidez, possível fora dos quadros jurídicos, é mantida sob o selo do segredo e dá pequeno vislumbre da dinâmica anterior da decisão.A antecipação da deficiência durante o pré-natal dissemina o medo do retardo mental, do sofrimento para a criança, para o casal ou irmãos, mas o discurso varia de acordo com o contexto: a análise comparativa de observações destaca que na França, os médicos utilizam a medicina baseada em evidências para informar o casal e reduzir o risco e a incerteza, tendo em vista uma escolha necessária e o respeito à autonomia das decisões dos casais. No Brasil, no hospital público, a hierarquia de prioridades é diferente: tornar-se mãe, ter um filho vivo vêm em primeiro plano. O risco é apresentado como parte da vida e a dinâmica da incerteza salvaguarda o futuro do filho doente no seio de sua família. Estas abordagens diferenciadas de risco e deficiência nos remetem ainda mais aos recentes achados nas áreas da deficiência, que pouco penetraram no universo do DPN. Impulsionados principalmente pela área dos « disability studies », pesquisas conduzidas pelas próprias pessoas afetadas pela deficiência, esses estudos consideram a deficiência como um processo dinâmico, resultante de uma interação entre um estado de saúde e uma situação social determinada. A tese apresenta como conclusao a necessidade da aproximaçao entre o universo do pré-natal e o da deficiência, por meio de um diálogo inter e transdisciplinar, compartilhando conhecimentos, experiências e práticas.